- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 25–36 of 43
Potential Harms of rhGH Treatment to Patients With CF
Potential Harms of rhGH Treatment to Patients With CF: Glucose Control and CFRD (1)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: pancreatic | beta cells | insulin | insulin sensitivity | glucose | CFRD | CF-related diabetes | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Potential Harms of rhGH Treatment to Patients With CF: Glucose Control and CFRD (2)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: A1c | CF | CF-related diabetes | CFRD | HGH | cystic fibrosis | glucose intolerance | hemoglobin A1c | human growth hormone | recombinant human growth hormone | rhGH | fasting blood glucose
Potential Harms of rhGH Treatment to Patients With CF: Cancer Risk (1)
Potential Harms of rhGH Treatment to Patients With CF: Cancer Risk (2)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: IGF-I | insulin-like growth factor | binding protein | IGFBP-3 | biomarker | cancer | risk | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Potential Harms of rhGH Treatment to Patients with CF: Cancer Risk (3)
Summary of Harms
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: harms | adverse events | adverse effects | withdrawals | blood glucose | glucose control | cancer | risk | biomarker | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Conclusions About Benefits and Harms (1)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: hospitalization | weight | mortality | risk | bone mineral content | BMC | fracture | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Conclusions About Benefits and Harms (2)
Knowledge Gaps and Future Research Needs (1)
Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: effectiveness | harms | benefits | dosage | duration | pubertal | clinical | nutritional | cystic fibrosis | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Knowledge Gaps and Future Research Needs (2)
What To Discuss With Your Patients and Their Caregivers
Your slide tray is being processed.


E-mail Updates










